Impaired cardiometabolic responses to glucagon-like peptide 1 in obesity and type 2 diabetes mellitus-Reference-Cited by-同舟云学术

Impaired cardiometabolic responses to glucagon-like peptide 1 in obesity and type 2 diabetes mellitus

Published:2013-06-14 Issue:4 Volume:108 Page:
ISSN:0300-8428
Container-title:Basic Research in Cardiology
language:en
Short-container-title:Basic Res Cardiol

Author:

Moberly Steven P.,Mather Kieren J.,Berwick Zachary C.,Owen Meredith K.,Goodwill Adam G.,Casalini Eli D.,Hutchins Gary D.,Green Mark A.,Ng Yen,Considine Robert V.,Perry Kevin M.,Chisholm Robin L.,Tune Johnathan D.

Publisher

Springer Science and Business Media LLC

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine,Physiology

Link

http://link.springer.com/content/pdf/10.1007/s00395-013-0365-x.pdf

Reference46 articles.

1. Ban K, Noyan-Ashraf MH, Hoefer J, Bolz SS, Drucker DJ, Husain M (2008) Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways. Circulation 117:2340–2350. doi: 10.1161/CIRCULATIONAHA.107.739938

2. Ben-Shlomo S, Zvibel I, Shnell M, Shlomai A, Chepurko E, Halpern Z, Barzilai N, Oren R, Fishman S (2011) Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase. J Hepatol 54:1214–1223. doi: 10.1016/j.jhep.2010.09.032

3. Berwick ZC, Dick GM, Tune JD (2012) Heart of the matter: coronary dysfunction in metabolic syndrome. J Mol Cell Cardiol 52:848–856. doi: 10.1016/j.yjmcc.2011.06.025

4. Bhashyam S, Fields AV, Patterson B, Testani JM, Chen L, Shen YT, Shannon RP (2010) Glucagon-like peptide-1 increases myocardial glucose uptake via p38alpha MAP kinase-mediated, nitric oxide-dependent mechanisms in conscious dogs with dilated cardiomyopathy. Circ Heart Fail 3:512–521. doi: 10.1161/CIRCHEARTFAILURE.109.900282

5. Bose AK, Mocanu MM, Carr RD, Brand CL, Yellon DM (2005) Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury. Diabetes 54:146–151. doi: 10.2337/diabetes.54.1.146

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advantages of glucagon-like peptide-1 receptor agonists in the treatment of patients with type 2 diabetes mellitus: A review;Terapevticheskii arkhiv;2023-11-23

2. Advances in Metabolic Remodeling and Intervention Strategies in Heart Failure;Journal of Cardiovascular Translational Research;2023-10-16

3. Interventions to Address Cardiovascular Risk in Obese Patients: Many Hands Make Light Work;Journal of Cardiovascular Development and Disease;2023-07-31

4. Chronic high-rate pacing induces heart failure with preserved ejection fraction-like phenotype in Ossabaw swine;Basic Research in Cardiology;2022-10-12

5. Liquiritin Attenuates Pathological Cardiac Hypertrophy by Activating the PKA/LKB1/AMPK Pathway;Frontiers in Pharmacology;2022-05-03